Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CTSC | P53634 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPY1R | P25929 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NPY2R | P49146 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7067885 | 0.77 | EGLN1 (0.44) | SMN1; SMN2 | |
| SCHEMBL7073731 | 0.73 | ALDH1A1 (0.37) | ALDH1A1HTTSMN1; SMN2MEN1MAPT | |
| SCHEMBL7071481 | 0.72 | ANO1 (0.37) | ALDH1A1HTTSMN1; SMN2KMT2A | |
| SCHEMBL7088346 | 0.71 | SMN1; SMN2 (0.38) | ALDH1A1HTTSMN1; SMN2MAPTKMT2A | |
| SCHEMBL7253284 | 0.70 | ALDH1A1 (0.36) | ALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL24769870 | 0.68 | — | — | |
| SCHEMBL3566444 | 0.67 | LMNA (0.42) | ALDH1A1HTTSMN1; SMN2MAPTMAPK1 | |
| SCHEMBL7084526 | 0.65 | ALDH1A1 (0.34) | ALDH1A1HTTSMN1; SMN2MAPK1 | |
| SCHEMBL7084982 | 0.65 | ALDH1A1 (0.34) | ALDH1A1HTTSMN1; SMN2MAPK1 | |
| Isopropylamine SCHEMBL9466355 | 0.65 | ALDH1A1 (0.35) | ALDH1A1HTTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6552056-B2 | Bactericides; fungicides; miticides; nematocides; for agriculture | NIHON BAYER AGROCHEM K.K. (JP) | 2003-04-22 | — | — | US | disclosed |
| US-20030013750-A1 | Isothiazolecarboxamides and their use as microbicides | NIHOM BAYER AGROCHEM K.K. (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1185519-A1 | ISOTHIAZOLECARBOXAMIDES AND THEIR USE AS MICROBICIDES | NIHON BAYER AGROCHEM K.K. (JP) | 2002-03-13 | — | — | EP | disclosed |
| WO-2000073290-A1 | ISOTHIAZOLECARBOXAMIDES AND THEIR USE AS MICROBICIDES | NIHON BAYER AGROCHEM K.K. (JP) | 2000-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013750-A1 | Isothiazolecarboxamides and their use as microbicides | MCL1, MSR1, MPO | ALDH1A1 591/4885HTT 4639/4885SMN1; SMN2 4471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.